CNS Stimulant Potentiation of Monoamine Oxidase: Inhibitors in Treatment-Refractory Depression
The DOI matches its Crossref record.
Abstract
We report on our clinical experience with a combination of a CNS stimulant (either pemoline or dextroamphetamine) and a monoamine oxidase inhibitor (MAOI) for treating 32 depressed patients (mainly outpatients) refractory to standard antidepressant pharmacotherapy. This combination, though not approved by the FDA, appears to be safe and effective. Twenty-five (78%) of these patients experienced at least 6 months of symptom remission with a stimulant + MAOI combination. Many patients required adjunctive antidepressant treatment, including tricyclics and lithium. Side effects were not excessive, though 6 patients (3 unipolar and 3 bipolar) cycled to mania (N = 1) or hypomania (N = 5). None developed hypertensive crises. With properly motivated and complaint patients and careful clinical monitoring by the prescribing psychiatrist, stimulant potentiation of MAOIs may be a viable option for treatment-resistant depressed patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Methylphenidate: Its Pharmacology and Uses
CHALLMAN, T. D., & LIPSKY, J. J. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64618-1 · Cited by 553
(2007) · PubMed · Cited by 453
MAOIs in the Contemporary Treatment of Depression
Thase, M. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00058-8 · Cited by 301
A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104910.75206.b9 · Cited by 144
Markowitz, J. S., & Patrick, K. S. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140100-00004 · Cited by 123
Metadata
- Authors
- FAWCETT, J., KRAVITZ, H. M., ZAJECKA, J. M., SCHAFF, M. R., & FREISHTAT, H. W.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 1991-04
- Volume
- 11
- Issue
- 2
- Pages
- 127???132
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2070159228
- Cited by
- 118
- References
- 0
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CNS Stimulant Potentiation of Monoamine Oxidase: Inhibitors in Treatment-Refractory Depression. https://app.cochat.ai/papers/10.1097/00004714-199104000-00010
- The paper
- FAWCETT, J., KRAVITZ, H. M., ZAJECKA, J. M., SCHAFF, M. R., & FREISHTAT, H. W. (1991). CNS Stimulant Potentiation of Monoamine Oxidase: Inhibitors in Treatment-Refractory Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199104000-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.